ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,261.80
0.50%
S&P ASX All Technology
3,859.50
0.90%
Brent Oil
73.44
0.00%
US Dollar vs AUD
1.61005
0.00%
Bitcoin
94,468.25
0.33%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Artelo Biosciences Inc (ARTL) Share Price

Artelo Biosciences Inc

Artelo Biosciences Inc (ARTL)

Alpha Real Trust Limited
1.06
0.0145
(1.39%)
Closed 28 December 8:00AM
Delayed by 15 minutes
1.06
0.00
(0.00%)
After Hours: 9:16AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.06
Bid
1.00
Offer
1.14
Volume
34,558
1.0101 Day's Range 1.0812
0.91 52 Week Range 1.75
Market Cap
3.421M
Previous Close
1.0455
Open
1.05
Last Trade
34
@
1.04
Last Trade Time
Financial Volume
US$ 36,591
VWAP
1.0588
Average Volume (3m)
30,423
Shares Outstanding
3,227,700
Dividend Yield
-
PE Ratio
-0.37
Earnings Per Share (EPS)
-2.88
Revenue
-
Net Profit
-9.29M

About Artelo Biosciences Inc

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approa... Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.artelobio.com
Headquarters
Fernley, Nevada, USA
Founded
-
Artelo Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARTL. The last closing price for Artelo Biosciences was US$1.05. Over the last year, Artelo Biosciences shares have traded in a share price range of US$ 0.91 to US$ 1.75.

Artelo Biosciences currently has 3,227,700 shares in issue. The market capitalisation of Artelo Biosciences is US$3.37 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.37.

Ask ADVFN Intelligence (AI)

ARTL Latest News

More News

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia

SOLANA BEACH, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

10 December 2024
GlobeNewswire Inc.

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit 

SOLANA BEACH, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

19 November 2024
GlobeNewswire Inc.

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium

SOLANA BEACH, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

14 November 2024
GlobeNewswire Inc.

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

SOLANA BEACH, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

13 November 2024
GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

09 November 2024
Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders

09 November 2024
Edgar (US Regulatory)

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program

SOLANA BEACH, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

06 November 2024
GlobeNewswire Inc.

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th

SOLANA BEACH, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

10 October 2024
GlobeNewswire Inc.

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to...

04 September 2024
GlobeNewswire Inc.

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

SOLANA BEACH, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

13 August 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.13514.59459459460.9251.060.91241000.98951111CS
4001.061.2740.91448381.10397241CS
12-0.05-4.50450450451.111.320.91304231.14485921CS
26-0.29-21.48148148151.351.550.91541271.27669421CS
52-0.23-17.82945736431.291.750.91345851.31388129CS
1560.459976.63722712880.60017.20.25992429531.27955984CS
260-1.79-62.80701754392.857.20.259912242201.41371135CS

ARTL - Frequently Asked Questions (FAQ)

What is the current Artelo Biosciences share price?
The current share price of Artelo Biosciences is US$ 1.06
How many Artelo Biosciences shares are in issue?
Artelo Biosciences has 3,227,700 shares in issue
What is the market cap of Artelo Biosciences?
The market capitalisation of Artelo Biosciences is USD 3.37M
What is the 1 year trading range for Artelo Biosciences share price?
Artelo Biosciences has traded in the range of US$ 0.91 to US$ 1.75 during the past year
What is the PE ratio of Artelo Biosciences?
The price to earnings ratio of Artelo Biosciences is -0.37
What is the reporting currency for Artelo Biosciences?
Artelo Biosciences reports financial results in USD
What is the latest annual profit for Artelo Biosciences?
The latest annual profit of Artelo Biosciences is USD -9.29M
What is the registered address of Artelo Biosciences?
The registered address for Artelo Biosciences is 564 WEDGE LANE, FERNLEY, NEVADA, 89408
What is the Artelo Biosciences website address?
The website address for Artelo Biosciences is www.artelobio.com
Which industry sector does Artelo Biosciences operate in?
Artelo Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
US$ 2.167
(381.56%)
187.57M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
557.72M
HUBCWHub Cyber Security Ltd
US$ 0.035
(250.00%)
2.65M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.75M
LITMSnow Lake Resources Ltd
US$ 1.61
(82.95%)
129.92M
NEUPNeuphoria Therapeutics Inc
US$ 4.11
(-92.30%)
936.47k
VIRXViracta Therapeutics Inc
US$ 0.16
(-32.49%)
9.31M
PRFXPainReform Ltd
US$ 3.48
(-28.98%)
926.19k
AIREreAlpha Tech Corporation
US$ 2.56
(-28.49%)
8.26M
AVGRAvinger Inc
US$ 0.9721
(-24.05%)
2.11M
AILEiLearningEngines Inc
US$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
US$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
US$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
US$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
US$ 3.585
(66.74%)
256.01M

ARTL Discussion

View Posts
glenn1919 glenn1919 1 month ago
ARTL.......................https://stockcharts.com/h-sc/ui?s=ARTL&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 5 months ago
ARTL
👍️0
glenn1919 glenn1919 5 months ago
artl.........................................https://stockcharts.com/h-sc/ui?s=ARTL&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 months ago
ARTL under $2
👍️0
Monksdream Monksdream 9 months ago
ARTL under $2
👍️0
Monksdream Monksdream 10 months ago
ARTL under $2
👍️0
Monksdream Monksdream 1 year ago
ARTL under $2
👍️0
heyitsmeagain heyitsmeagain 2 years ago
Added
👍️0
heyitsmeagain heyitsmeagain 2 years ago
I’m back ! I’m in pamp
👍️0
heyitsmeagain heyitsmeagain 2 years ago
Grabbed 7000 more
👍️0
tw0122 tw0122 2 years ago
Already traded entire float one time let’s do this about 4 more times…
👍️0
tw0122 tw0122 2 years ago
Now only 2 million float can squeeze to $10 easily. Just a little patience
👍️0
pistolpete pistolpete 2 years ago
Let’s go $ARTL!!
👍️0
heyitsmeagain heyitsmeagain 2 years ago
We gonna go artelo $ARTL
👍️0
heyitsmeagain heyitsmeagain 2 years ago
Got 6000 shares ready to sell at 20
👍️0
heyitsmeagain heyitsmeagain 2 years ago
Booyaaaaakashaaaa
👍️0
Arcglass Arcglass 2 years ago
surprised nobody's here yet.
👍️0
Awl416 Awl416 3 years ago
News
👍️0
Jake L Jake L 3 years ago
ARTL - Friday Rundown, Monday Expectations

👍️0
Jake L Jake L 3 years ago
ARTL - Thursday Rundown, Friday Expectations

👍️0
Jake L Jake L 3 years ago
ARTL - Update

👍️0
Jake L Jake L 3 years ago
ARTL - Wednesday Rundown, Thursday Expectations

👍️0
KLee KLee 3 years ago
Sorry guys, wrong board. Blah!
👍️0
KLee KLee 3 years ago
I have been scooping up so many shares as we dipped under a penny. But that little voice keeps telling me when we blast past our highest I’m going to wish I had scooped more at these levels, trying NOT to be greedy, but damn!!

#CBDD
👍️0
Jake L Jake L 3 years ago
ARTL - Earnings Insight/Outlook

👍️0
BUFCARP BUFCARP 3 years ago
More like four wainwright will move this .. look for news coming shortly!
👍️0
shimanoman shimanoman 3 years ago
.70’s here we come .
👍️0
Jake L Jake L 3 years ago
ARTL - Friday Rundown, Monday Expectations

👍️0
BUFCARP BUFCARP 3 years ago
Probably fake shares like most of the market
👍️0
BONGO68 BONGO68 3 years ago
https://www.chartmill.com/stock/analyzer/stock/ARTL
👍️0
masterofdisaster masterofdisaster 3 years ago
940,000 short exempts today
👍️0
masterofdisaster masterofdisaster 3 years ago
Looks like Fintel found shares
👍️0
masterofdisaster masterofdisaster 3 years ago
Last chance for cheapies
👍️0
Arcglass Arcglass 3 years ago
Here it comes
👍️0
Jess070283 Jess070283 3 years ago
Loading up here.$$$$
👍️0
Arcglass Arcglass 3 years ago
OS Has flipped almost 3 times.
👍️0
masterofdisaster masterofdisaster 3 years ago
I know but Fintel showing zero shares available. Short exempts will need to be covered
👍️0
BUFCARP BUFCARP 3 years ago
It’s getting to that point .. short interest is low though
👍️0
Arcglass Arcglass 3 years ago
$2.00 Target?
👍️0
make it happen make it happen 3 years ago
Is delinquent for not meeting NASDAQ listing requirements
👍️0
masterofdisaster masterofdisaster 3 years ago
ARTL MAY SQUEEZE!
👍️0
masterofdisaster masterofdisaster 3 years ago
Eating up those short shares.....yum....I am ready for the ride to $5
👍️0
masterofdisaster masterofdisaster 3 years ago
ARTL nice premarket volume
👍️0
doebop doebop 3 years ago
$$$ nice movement from the <$1 pullback
👍️0
masterofdisaster masterofdisaster 3 years ago
Easy plays for easy money.....lol
👍️0
Jake L Jake L 3 years ago
ARTL - Today

👍️0
Amrsto1000 Amrsto1000 3 years ago
Just came aboard with 25,000.
👍️0
BUFCARP BUFCARP 3 years ago
After that buy rating by wainwright
👍️0
make it happen make it happen 3 years ago
It is delinquent.
👍️0
TIZZUNI TIZZUNI 3 years ago
The stock is alive and running this morning!
👍️0

Your Recent History

NASDAQ
ARTL
Artelo Biosciences
BIT
3BUS
WisdomTree BUND 10Y 3x D...
BIT
BIE
Bioera
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads